Text Size
983 studies found for:    "Genentech" [Exact]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed A Continued Access Protocol to Provide Xolair to Patients With Severe Allergic Asthma
Condition: Asthma
Intervention: Drug: Xolair (omalizumab)
2 Completed A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion
Condition: Macular Edema
Intervention: Drug: ranibizumab
3 Completed A Study to Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g
Condition: Psoriasis
Intervention: Drug: Raptiva (efalizumab)
4 Completed
Has Results 		A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE)
Condition: Small Cell Lung Cancer
Interventions: Drug: Bevacizumab;   Drug: Chemotherapy;   Drug: Placebo
5 Recruiting A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
Condition: Asthma
Interventions: Drug: MEMP1972A;   Drug: placebo
6 Active, not recruiting
Has Results 		A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: folate;   Drug: methotrexate;   Drug: methylprednisolone;   Drug: placebo;   Drug: rituximab
7 Active, not recruiting GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid Tumors
Condition: Solid Cancers
Interventions: Drug: bevacizumab;   Drug: capecitabine;   Drug: GDC-0980;   Drug: mFOLFOX6
8 Recruiting A Study of Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Plus Platinum in Patients With Squamous Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: onartuzumab;   Drug: Placebo;   Drug: paclitaxel;   Drug: cisplatin/carboplatin
9 Suspended A Study of GDC-0199 (ABT-199) in Combination With Bendamustine And MabThera/Rituxan in Patients With Chronic Lymphocytic Leukemia
Condition: Lymphocytic Leukemia, Chronic
Interventions: Drug: GDC-0199 (ABT-199);   Drug: rituximab [MabThera/Rituxan];   Drug: bendamustine
10 Active, not recruiting A Study Comparing RO5072759 (GA101) 1000 mg Versus 2000 mg in Patients With Previously Untreated Chronic Lymphocytic Leukemia (GAGE)
Condition: Lymphocytic Leukemia, Chronic
Intervention: Drug: RO5072759
11 Terminated A Safety and Efficacy Study of Xolair in Peanut Allergy
Condition: Allergy
Intervention: Drug: Xolair (omalizumab)
12 Completed A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung Disease
Condition: Cystic Fibrosis
Intervention:
13 Completed A Study of Avastin in Combination With Chemotherapy for Treatment of Colorectal Cancer and Non-Small Cell Lung Cancer (ARIES)
Conditions: Colorectal Cancer;   Non-Small Cell Lung Cancer
Intervention:
14 Completed A Study to Evaluate the Safety, Tolerability, and Activity of Intravenous MLDL1278A in Patients on Standard-of-Care Therapy for Stable Atherosclerotic Cardiovascular Disease (GLACIER)
Condition: Atherosclerosis
Interventions: Drug: MLDL1278A;   Drug: placebo;   Drug: statin, stable dose
15 Active, not recruiting A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: bevacizumab;   Drug: placebo;   Drug: erlotinib HCl
16 Completed A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate
Condition: Rheumatoid Arthritis
Interventions: Drug: methotrexate;   Drug: methylprednisolone;   Drug: rituximab
17 Completed
Has Results 		A Study of MetMAb Administered to Patients With Advanced Non-Small Cell Lung Cancer, in Combination With Tarceva (Erlotinib)
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Erlotinib HCl;   Drug: MetMAb;   Drug: placebo (0.9 % saline)
18 Active, not recruiting A Study of GDC-0941 in Patients With Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable
Condition: Solid Cancers
Intervention: Drug: GDC-0941
19 Recruiting A Drug Interaction Study of GDC-0032 Co-administered With Rifampin or Itraconazole in Healthy Volunteers
Condition: Healthy Volunteer
Interventions: Drug: GDC-0032;   Drug: Rifampin;   Drug: Itraconazole
20 Terminated
Has Results 		A Study for Patients Previously Enrolled in Study U2971g to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: methylprednisolone;   Drug: rituximab
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years